Phase II Study of Navelbine oral and Arimidex as neo-adjuvant treatment in post-menopausal women with locally advanced breast carcinoma
Phase II Study of Navelbine oral and Arimidex as neo-adjuvant treatment in post-menopausal women with locally advanced breast carcinoma
Phase II Study of Navelbine oral and Arimidex as neo-adjuvant treatment in post-menopausal women with locally advanced breast carcinoma
Status
Status :
Completed
Type of study
Phase II
Min. Age
60
Years old
Max. Age
-
Gender
Female
Therapeutic area :
Oncology
Disease :
Breast cancer
Study medication :
Vinorelbine (Navelbine® Oral)
Phase :
Phase II
Start Date :
11 July 2005
End date :
03 February 2009
Study ID :
PM0259 CA 217 B0
EudraCT/CTIS number :
2004-000962-11
Send by email